Drug profile · INN
naldemedine tosylate
SYMPROIC
naldemedine tosylate (SYMPROIC) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — naldemedine tosylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
naldemedine tosylate (SYMPROIC) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor antagonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is naldemedine tosylate?
naldemedine tosylate (SYMPROIC) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for naldemedine tosylate?
SYMPROIC is a marketed brand name for naldemedine tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naldemedine tosylate?
naldemedine tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.